SPONSOR
Haisco Pharmaceutical Group Co., Ltd.
Total Trials
3
Recruiting
3
Phases
Phase 2, Phase 1
Haisco Pharmaceutical Group Co., Ltd. is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including IgA Nephropathy (IgAN), Healhty, Pain After Surgery.
The trial portfolio spans Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Haisco Pharmaceutical Group Co., Ltd.
How many clinical trials has Haisco Pharmaceutical Group Co., Ltd. sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Haisco Pharmaceutical Group Co., Ltd., of which 3 are actively recruiting participants. These trials cover conditions including IgA Nephropathy (IgAN), Healhty, Pain After Surgery. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Haisco Pharmaceutical Group Co., Ltd. research focus on?
Haisco Pharmaceutical Group Co., Ltd. clinical trials span IgA Nephropathy (IgAN), Healhty, Pain After Surgery. The research pipeline includes Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Haisco Pharmaceutical Group Co., Ltd. clinical trial?
To participate in a Haisco Pharmaceutical Group Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Haisco Pharmaceutical Group Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Haisco Pharmaceutical Group Co., Ltd.
NCT07616700 Phase 2
Recruiting
A Study to Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA Nephropathy
IgA Nephropathy (IgAN)
NCT07521345 Phase 1
Recruiting
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Food Effect of HSK55879 Tablets in Healthy Subjects.
Healhty
NCT07533786 Phase 2
Recruiting
A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Abdominal Surgery
Pain After Surgery
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology